← All diseases Cancer

Multiple myeloma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (64)Meta-analysis (11)Treatment guideline (2)Systematic review (24)Randomized trial (16)Phase 3 study (11)Clinical trial (628)Review Article (260)Early study (phase 1 or 2) (44)Case Reports (256)Laboratory or animal study (23)Commentary or editorial (45)Retracted Publication (4)Concerns have been raised (1) Studies currently recruiting participants only (46)

Filter

Publications and studies (2183)

• Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment. (2025/11/12) ♡
• Correction: Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax. (2025/11/11) ♡
• Evaluating pre-transplant nutritional indices as predictors of pneumonia and mortality in multiple myeloma patients post-autologous stem cell transplantation. (2025/11/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting. (2025/11/08) ♡
• Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma. (2025/11/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case reports of acupuncturists and massage therapists at Mayo Clinic: New allies in expediting patient diagnoses. (2025/11/01) ♡
• Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress. (2025/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbiota in cancer care: Clinical prospects. (2025/11/01) ♡
• Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework. (2025/10/31) ♡
• Body Composition Metrics Associated with Time to Progression in Smoldering Multiple Myeloma. (2025/10/31) ♡
• Impact of pretransplant vitamin D deficiency on immune recovery and clinical outcomes in multiple myeloma patients undergoing autologous stem cell transplantation. (2025/10/31) ♡
• Detection and clinical significance of peripheral blood myeloid-derived suppressor cells in patients with multiple myeloma. (2025/10/31) ♡
• Home-based treatment for patients with hematological cancer in Denmark-A national overview. (2025/10/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Daratumumab Versus Control Treatment: A Systematic Review and Meta-analysis Study of Survival Outcomes Among Multiple Myeloma Patients : Survival Outcomes of Multiple Myeloma Treatment with Daratumumab. (2025/10/21) ♡
• DNA Damage Response and Redox Status in the Resistance of Multiple Myeloma Cells to Genotoxic Treatment. (2025/10/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimising multiple myeloma therapy in resource-limited settings: current perspectives and challenges. (2025/10/06) ♡
• Emphysematous osteomyelitis in hematological malignancies: tales of two cases. (2025/10/06) ♡
• Exploring the Relationship Between Daratumumab Treatment and Stem Cell Collection in Newly Diagnosed Multiple Myeloma (NDMM) Patients Undergoing Transplantation: Insights From a Single-Center Investigation. (2025/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Co-occurrence of RUNX1::RUNX1T1 Translocation-Positive Acute Myeloid Leukemia and Smouldering Multiple Myeloma: An Uncommon Case. (2025/10/01) ♡
• Low Dose Cyclophospahamide is a Feasable Mobilization Regimen in the Covid-19 Era: A Single Center Study from Türkiye. (2025/10/01) ♡
• Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vaccination in Multiple Myeloma: Challenges and Strategies. (2025/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy. (2025/10/01) ♡
• Nutritional status indices on the prognosis of patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy. (2025/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Polyclonal Hypergammaglobulinemia Associated With Multimorbidity and Malnutrition in an Elderly Man: A Comprehensive Diagnostic Approach. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRD in multiple myeloma: From an early endpoint for accelerated approval to MRD driven treatment and clinical management. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRD as an early endpoint in myeloma and other hematologic malignancies: Implication for ongoing and future study designs. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeted immunoPET imaging of multiple myeloma. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Blood-based MRD testing in multiple myeloma: Update on mass spectrometry methods for detecting the monoclonal immunoglobulin. (2025/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ulcerated Tongue Borders as a Sign of Amyloidosis in a Patient with Multiple Myeloma. (2025/10/01) ♡
• Incidence and trends of multiple myeloma (MM) in Brazil - 1988-2020. (2025/09/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Underestimated Cause of Hypercalcemia: A Case Report of Milk-Alkali Syndrome. (2025/09/23) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis. (2025/09/19) ♡
• Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities. (2025/09/12) ♡
• Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma. (2025/09/03) ♡
• Increased cellular uptake and proteasome inhibition of carfilzomib through the optimized self-nanoemulsifying drug delivery system. (2025/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent versus combination drugs. (2025/09/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical, biochemical, and molecular findings in adults with hyperammonemia: A French bi-centric retrospective study. (2025/09/01) ♡
• Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma. (2025/08/29) ♡
• Presentation, treatment and clinical outcomes in young multiple myeloma patients treated at a tertiary care centre in a low middle-income country. (2025/08/29) ♡
• Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes. (2025/08/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Synergistic Mechanisms of Traditional Chinese Medicine and Proteasome Inhibitors in Multiple Myeloma Therapy: A Comprehensive Review. (2025/08/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Study on Risk Factors and Treatment Strategies for Deep Vein Thrombosis in Patients with Multiple Myeloma. (2025/08/15) ♡
• Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax. (2025/08/14) ♡
• Investigating the impact of an efficacy-based nursing program integrated with nutritional intervention strategies on the outcomes of multiple myeloma patients with renal failure. (2025/08/12) ♡
• Dujieqing decoction suppresses multiple myeloma growth by inhibiting the Wnt/β-catenin pathway. (2025/08/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Medical and Nutritional Outcomes Are Similar Among Autologous Transplant Patients on Enteral Nutrition When Compared to Parenteral Nutrition. A Randomized Pilot Study. (2025/08/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients. (2025/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Liver in Hematologic Malignancies: Lymphoma, Leukemia, and Myeloma. (2025/08/01) ♡
• [Prognostic Significance of Inflammation Score and Nutrition-Immunity Score in Patients with Newly Diagnosed Multiple Myeloma]. (2025/08/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.